JAGX logo

Jaguar Health (JAGX)

Profile

Full Name

Jaguar Health, Inc.

Ticker Symbol

JAGX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

May 12, 2015

Indexes

Not included

Website

http://jaguar.health

Employees

49

Key Details

Price

$5.51(-1.80%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$11.69M(+19.75% YoY)

Annual EPS

-$130.69(+95.12% YoY)

PE ratio

-

Next earnings date

May 14, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$5.51
JAGX price is $5.51

30-Day Relative Volume

0.13
JAGX 30-day relative volume is 0.13

Price Performance

Price Most recent change

-1.8%
JAGX price was down -1.8% on Apr 17, 2025

Price YTD change

+445.54%
JAGX price is up +445.54% since January 1st

Price 1-year change

-44.34%
JAGX price is down -44.34% year-on-year

Price 3-year change

-99.78%
JAGX price is down -99.78% over the past 3 years

Price Range

Price All-time high

$100075504.00
JAGX price is currently -100.00% below its historical high of $100075504.00

Price 3-year low

$0.47
JAGX price is currently +1072.34% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$3.62M
JAGX market capitalization is $3.62 million

Market cap 3-year change

+103.48%
JAGX market capitalization is up +103.48% over the past 3 years

Market cap All-time high

$17.98M
JAGX market capitalization is currently -79.90% below its historical high of $17.98 million

Market cap sector rank

10.12%
JAGX market capitalization is higher than 10.12% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+242.61%
JAGX shares outstanding is up +242.61% year-on-year

Shares Outstanding 3-Year Change

+93628.57%
JAGX shares outstanding is up +93628.57% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

4.67
JAGX beta is 4.67

200-day SMA

$1.94
JAGX price is currently +184.23% above its 200-day simple moving average

50-day SMA

$3.68
JAGX price is currently +49.55% above its 50-day simple moving average

RSI

55.67
JAGX 14-day relative strength index is 55.67

Volume

0.13
JAGX 30-day relative volume is 0.13

ATR

$0.87
JAGX average true range is $0.87

10-day Historical Volatility

97.25%
JAGX 10-day historical volatility is 97.25%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$11.69M
JAGX annual revenue is $11.69 million

Revenue Analysts estimate

$15.84M
JAGX annual revenue is currently -26.21% lower than the consensus analysts' forecast

Revenue 1-year change

+19.75%
JAGX annual revenue is up +19.75% year-on-year

Revenue Sector rank

30.04%
JAGX annual revenue is higher than 30.04% of companies in Healthcare sector

EPS

EPS

-$130.69
JAGX annual earnings per share is -$130.69

EPS Analysts estimate

-$51.50
JAGX annual earnings per share is currently +153.77% higher than the consensus analysts' forecast

EPS 1-year change

+95.12%
JAGX annual earnings per share is up +95.12% year-on-year

EPS Sector rank

1.66%
JAGX annual earnings per share is higher than 1.66% of companies in Healthcare sector

Profit

Gross profit

$9.73M
JAGX annual gross profit is $9.73 million

Gross margin

83.27%
JAGX annual gross profit margin is 83.27%

Operating profit

-$30.83M
JAGX annual operating income is -$30.83 million

Operating margin

-263.76%
JAGX annual operating profit margin is -263.76%

Net income

-$38.49M
JAGX annual net profit is -$38.49 million

Net margin

-329.30%
JAGX annual net profit margin is -329.30%

Expenses

Total expenses

$42.52M
JAGX annual total expenses is $42.52 million

Operating expenses

$40.56M
JAGX annual total operating expenses is $40.56 million

Cost of goods sold

$1.96M
JAGX annual cost of goods sold is $1.96 million

Selling, general & administrative expenses

$24.02M
JAGX annual SGA is $24.02 million

Depreciation and amortization

$2.36M
JAGX annual depreciation & amortization is $2.36 million

Interest expense

$231.00K
JAGX annual interest expense is $231.00 thousand

Income tax

$0.00
JAGX annual income tax is $0.00

EBIT & EBITDA

EBIT

-$39.02M
JAGX annual earnings before interest & taxes is -$39.02 million

EBITDA

-$36.66M
JAGX annual EBITDA is -$36.66 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$53.42M
JAGX annual total assets is $53.42 million

Non current assets

$21.23M
JAGX annual long term assets is $21.23 million

Current assets

$32.20M
JAGX annual total current assets is $32.20 million

Cash and cash equivalents

$8.00M
JAGX annual cash & cash equivalents is $8.00 million

Accounts receivable

$1.53M
JAGX annual accounts receivable is $1.53 million

Inventory

$10.35M
JAGX annual inventory is $10.35 million

Liabilities

Total liabilities

$46.93M
JAGX annual total liabilities is $46.93 million

Long term liabilities

$27.23M
JAGX annual total long term liabilities is $27.23 million

Current liabilities

$19.70M
JAGX annual total current liabilities is $19.70 million

Accounts payable

$5.29M
JAGX annual accounts payable is $5.29 million

Debt

Total debt

$36.53M
JAGX annual total debt is $36.53 million

Total debt 1-year change

-1.53%
JAGX annual total debt is down -1.53% year-on-year

Long term debt

$24.19M
JAGX annual long term debt is $24.19 million

Short term debt

$12.34M
JAGX annual short term debt is $12.34 million

Equity & Capital

Shareholders equity

$7.29M
JAGX annual stockholders equity is $7.29 million

Book value

$7.29M
JAGX annual book value is $7.29 million

Retained earnings

-$346.48M
JAGX annual retained earnings is -$346.48 million

Working capital

$12.49M
JAGX annual working capital is $12.49 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$29.38M
JAGX annual cash flow from operations is -$29.38 million

Cash from operations 1-year change

+11.61%
JAGX annual cash flow from operations is up +11.61% year-on-year

Cash from investing

-$231.00K
JAGX annual cash flow from investing activities is -$231.00 thousand

Cash from investing 1-year change

-100%
JAGX annual cash flow from investing activities is down -100% year-on-year

Cash from financing

$31.20M
JAGX annual cash flow from financing activities is $31.20 million

Cash from financing 1-year change

-8.84%
JAGX annual cash flow from financing activities is down -8.84% year-on-year

CAPEX

CAPEX

$231.00K
JAGX annual capital expenditures is $231.00 thousand

CAPEX 1-year change

-
JAGX annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$29.61M
JAGX annual free cash flow is -$29.61 million

Free cash flow 1-year change

+10.91%
JAGX annual free cash flow is up +10.91% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

83.27%
JAGX annual gross profit margin is 83.27%

Operating margin

-263.76%
JAGX annual operating profit margin is -263.76%

Net margin

-329.30%
JAGX annual net profit margin is -329.30%

ROA & ROE

ROA

-73.89%
JAGX annual return on assets is -73.89%

ROE

-675.83%
JAGX annual return on equity is -675.83%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
JAGX price to earnings ratio value is unknown

PE ratio Sector rank

-
JAGX price to earnings ratio is unknown

PB Ratio

PB ratio

0.50
JAGX price to book ratio is 0.50

PB ratio Sector rank

30.09%
JAGX price to book ratio is higher than 30.09% of companies in Healthcare sector

PS Ratio

PS ratio

0.31
JAGX price to sales ratio is 0.31

PS ratio Sector rank

10.53%
JAGX price to sales ratio is higher than 10.53% of companies in Healthcare sector

Enterprise value

Enterprise value

$32.14M
JAGX enterprise value is $32.14 million

Enterprise value Sector rank

36.12%
JAGX enterprise value is higher than 36.12% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.86
JAGX EV/EBITDA is -0.86

EV/EBITDA Sector rank

45%
JAGX EV/EBITDA is higher than 45% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.63
JAGX annual current ratio is 1.63

Quick ratio

1.11
JAGX annual quick ratio is 1.11

Leverage

Debt to equity

4.88
JAGX annual debt to equity ratio is 4.88

Interest coverage ratio

-168.92
JAGX annual interest coverage ratio is -168.92

Risk & Stability

Piotroski F-Score

4
JAGX piotroski f-score is 4

Altman Z-Score

-10.94
JAGX altman z-score is -10.94

Analyst ratings

Recent major analysts updates

Jul 7, 21 Cantor Fitzgerald
Overweight
Nov 25, 20 Rodman & Renshaw
Buy
Nov 25, 20 Ladenburg Thalmann
Buy
Nov 25, 20 H.C. Wainwright
Buy
Nov 25, 20 Aegis Capital
Buy
Nov 18, 19 H.C. Wainwright
Buy
Sep 12, 19 Ladenburg Thalmann
Buy
Jul 11, 17 Rodman & Renshaw
Buy
Nov 12, 15 Aegis Capital
Buy

Institutional Ownership

Similar stocks

XYLO logo
Xylo Technologies (XYLO)
XRTX logo
XORTX Therapeutics (XRTX)
HSCS logo
Heart Test Laboratories (HSCS)
MBIO logo
Mustang Bio (MBIO)
GENE logo
Genetic Technologies Limited (GENE)
SNOA logo
Sonoma Pharmaceuticals (SNOA)
KTTA logo
Pasithea Therapeutics (KTTA)
RSLS logo
ReShape Lifesciences (RSLS)
NBY logo
NovaBay Pharmaceuticals (NBY)
  • What is the ticker symbol for Jaguar Health?
  • Does Jaguar Health pay dividends?
  • What sector is Jaguar Health in?
  • What industry is Jaguar Health in?
  • What country is Jaguar Health based in?
  • When did Jaguar Health go public?
  • Is Jaguar Health in the S&P 500?
  • Is Jaguar Health in the NASDAQ 100?
  • Is Jaguar Health in the Dow Jones?
  • When was Jaguar Health's last earnings report?
  • When does Jaguar Health report earnings?
  • Should I buy Jaguar Health stock now?

What is the ticker symbol for Jaguar Health?

The ticker symbol for Jaguar Health is NASDAQ:JAGX

Does Jaguar Health pay dividends?

No, Jaguar Health does not pay dividends

What sector is Jaguar Health in?

Jaguar Health is in the Healthcare sector

What industry is Jaguar Health in?

Jaguar Health is in the Biotechnology industry

What country is Jaguar Health based in?

Jaguar Health is headquartered in United States

When did Jaguar Health go public?

Jaguar Health's initial public offering (IPO) was on May 12, 2015

Is Jaguar Health in the S&P 500?

No, Jaguar Health is not included in the S&P 500 index

Is Jaguar Health in the NASDAQ 100?

No, Jaguar Health is not included in the NASDAQ 100 index

Is Jaguar Health in the Dow Jones?

No, Jaguar Health is not included in the Dow Jones index

When was Jaguar Health's last earnings report?

Jaguar Health's most recent earnings report was on Mar 31, 2025

When does Jaguar Health report earnings?

The next expected earnings date for Jaguar Health is May 14, 2025

Should I buy Jaguar Health stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page